About Imu Biosciences
Unlocking the potential of the immune system. IMU's cutting-edge platform decodes complex immune challenges to drive breakthroughs and better health outcomes.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
London, United Kingdom
Year Founded
2021
Team Size
51-100
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
imubiosciences.com
Domain Registered Date
Aug 5, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $53,000,000 · Series-A
fundraisingfox.com
- Capital Raise
Raised $14,660,200 · Series-A
- Milestone
Website domain registered
imubiosciences.com
- Milestone
Company founded
London, United Kingdom
Investors & Backers
Beaumont Capital
British Business Bank
COREangels
Expa
IQ Capital
Life Extension Ventures
Meltwind Advisory
Molten Ventures
Funding History
Series-A
· Jun 1, 2026
$53,000,000 fundraisingfox.com
Series-A
· Jan 24, 2024
$14,660,200 Source
Founders & Leadership
Adam Laing
Co-founder & Chief Scientific Officer
Work email & phone locked
Unlock →
John Baker
CEO
Work email & phone locked
Unlock →
Mario Cantero MBA
Co-founder & Chief Operating Officer
Work email & phone locked
Unlock →
Thomas Hayday
Co-founder & Chief Research Officer
Work email & phone locked
Unlock →
Timothy Haines
Non Executive Chair
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026